The adherence of Bordetella bronchiseptica smooth-, intermediate-, and rough-phase isolates to hamster lung fibroblasts (HLF) (Don line) was characterized by competitive inhibition studies and enzyme and chemical treatments of both the bacteria and the HLF. The adherence of the rough-and intermediate-phase isolates (n = 13) was altered by coincubation of the bacteria and HLF with cationic chelators, including EGTA Adherence to mucosal surfaces is recognized as an important step in colonization and infection (9, 19) . The ability of a pathogen to bind to mammalian cells appears to be mediated by surface components on both the bacterium and the mammalian cell (12, 14) . Workers have been probing the nature of these surface components in inhibition studies (10, 15). Recent observations have suggested that sugar residues, amino sugars, glycolipids, or all of these on the surfaces of mammalian cells serve as receptors for certain human and animal pathogens (12, 15). Mannose or its derivatives were reported to specifically inhibit the adherence of Escherichia coli to epithelial cells (16). Further, certain E. coli strains were able to bind to globotetrasylceramide, a surface glycolipid of P+ human erythrocytes (12). N-Acetylneuraminic acid has also been shown to mediate the binding of Mycoplasma pneumonia to mammalian cells (3, 6). Although B. bronchiseptica adheres to a variety of cell types (1, 8), little is known about the surface structures involved in the bacterium-cell interaction. The purpose of this study was to investigate the effect of a variety of chemicals on the adherence of B. bronchiseptica to hamster lung fibroblasts (HLF), with an aim to elucidating the nature of the cell surface binding site(s).
bacteria also resulted in a loss of adherence. It was concluded that B. bronchiseptica can adhere to HLF by at least two mechanisms and that the ligand responsible appears to be a proteinacious, heat labile cell surface component.
Adherence to mucosal surfaces is recognized as an important step in colonization and infection (9, 19) . The ability of a pathogen to bind to mammalian cells appears to be mediated by surface components on both the bacterium and the mammalian cell (12, 14) . Workers have been probing the nature of these surface components in inhibition studies (10, 15) . Recent observations have suggested that sugar residues, amino sugars, glycolipids, or all of these on the surfaces of mammalian cells serve as receptors for certain human and animal pathogens (12, 15) . Mannose or its derivatives were reported to specifically inhibit the adherence of Escherichia coli to epithelial cells (16) . Further, certain E. coli strains were able to bind to globotetrasylceramide, a surface glycolipid of P+ human erythrocytes (12) . N-Acetylneuraminic acid has also been shown to mediate the binding of Mycoplasma pneumonia to mammalian cells (3, 6) . Although B. bronchiseptica adheres to a variety of cell types (1, 8) , little is known about the surface structures involved in the bacterium-cell interaction. The purpose of this study was to investigate the effect of a variety of chemicals on the adherence of B. bronchiseptica to hamster lung fibroblasts (HLF), with an aim to elucidating the nature of the cell surface binding site(s).
MATERIALS AND METHODS Bacterial strains. A total of 17 B. bronchiseptica isolates were used (Table 1) . These represented the three phases (smooth, intermediate, and rough) and were from five animal species. All cultures were maintained on brucella agar (Difco Laboratories, Detroit, Mich.). Because smooth-phase isolates undergo smooth-rough colony variation (isolates 110H and 110NH are isogenic), care was taken to ensure the selection of smooth colonies when subculturing. Rough colonies were morphologically stable. All initial inocula were made from cultures grown on brucella agar for 48 h.
Inocula for the adherence assay were prepared from an 18-h brucella broth culture by adjusting the absorbance of fresh broth to 0.05 (540 nm). The cells were incubated at 37°C until an optical density of 1.65 was obtained and then were harvested by centrifugation (12,000 x g, 30 min, 5°C); the pellet was suspended to an optical density of 0.1 in Tris-buffered saline (TBS) containing 0.4 M Trizma Base (Sigma Chemical Co., St. Louis, Mo.), 0.14 M NaCl, 0.1 mM CaC12, and 0.2 mM MgCl2 (pH 7.2).
Preparation of mammalian cells. HLF (Don line) were obtained from the American Type Culture Collection, Rockville, Md. HLF were grown in McCoy 5A medium with glutamate and 10% fetal bovine serum (GIBCO Laboratories, Grand Island, N.Y.). For the adherence assay, HLF were grown to confluency on glass cover slips at 37°C in 5% CO2 in air. Buccal cells were obtained from a human vofunteer and immediately suspended in TBS. The cells were washed (45 x g, 10 min, three times) and suspended to a concentration of 5 x 105 cells per ml of TBS.
Adherence assay. Adherence was assayed after bacterial suspensions, which contained 108 CFU, and HLF monolayers, which had been washed in three changes of TBS, were coincubated (37°C, 30 min) and then washed free of nonadherent bacteria, fixed, stained with crystal violet, and examined by light microscopy. The number of bacteria per cell was determined for a minimum of 50 cells on each of two cover slips. All experiments were repeated at least twice. The bacteria-to-cell ratio was ca. 1,000:1. A modification of the method of Gibbons and van Haute was used to assess adherence to human buccal epithelial cells (4) . A 1-ml portion of bacterial suspension was added to an equal volume of buccal cell suspension. The cells were incubated (30 min, 37°C) and then washed free of nonadherent bacteria, fixed, stained, and examined by light microscopy. All experiments were done in triplicate and repeated at least twice; a minimum of 300 cells were examined.
Chemicals. Various compounds were tested for their ability to inhibit B. bronchiseptica adherence. The compounds used were as follows: arabinose, xylose, lyxose, galactose, sorbose, fructose, glucose, rhamnose, fucose, mannose, (12 ,000 x g) to remove either surface components which had been sheared off or excess Formalin, respectively. The bacteria were then suspended in TBS (108 CFU/ml).
Fibroblast treatment. HLF were enzymatically treated before use with fucosidase (1 U/ml, 10 min), neuraminidase (2 U/ml, 10 min) or trypsin (0.25%, 5 min). The treatments were done at 25°C. Additionally, fixed HLF (acetoneethanol, 1:1 [vol/vol]) or HLF incubated (10 min) with a crude pilus preparation were used. Pili were isolated from bacteria by homogenization (see above). After bacterial cells were removed by centrifugation, the homogenization supernatant was subjected to a series of four high-speed centrifugation (100,000 x g, 6 h, 5°C). The final pellet was suspended in TBS containing 0.1 M MgCl2. The precipitate obtained after overnight incubation at 4°C was suspended in TBS and dialyzed against water. The dialysate was kept frozen until examination by EM and use in the adherence assay. After the above treatments were done, HLF were washed in three changes of TBS.
Reversal of adherence. Sodium citrate and GlcNAc were tested for their ability to release adherent bacteria from HLF. The adherence assay was performed as above, but before fixation, the cells were placed in either sodium citrate (0.2 mM) or GlcNAc (0.25 M) and then removed at 5-min intervals. Controls were incubated in TBS alone.
Cations were tested for their ability to block EGTA inhibition of adherence. For this, modified TBS was used (MgCl2 and CaCI2 were left out and 0.1 mM EGTA was added). To the reaction mixture a 0.5 mM concentration of the cation to be tested was added. The cations tested included the sodium salts of calcium, manganese, strontium, magnesium, lead, chloride, lithium, cesium, cadmium, potassium, barium, iron, mercury, zinc, and tin as well as zinc sulfate and ferric sulfate. Bacterial viability was not affected by modified TBS. Controls included HLF and bacteria in TBS without EGTA.
Binding of radiolabeled GIcNAc to B. bronchiseptica. Isolates 11OH, 87, and 11ONH (107 CFU/ml) were mixed with tritiated GlcNAc (40 LI of 5.11 x (Table 3 ). This was done by adding the cations to be tested to a reaction mixture containing bacteria, HLF, and EGTA. The divalent cations calcium, cadmium, strontium, and manganese restored the adherence of both isolates after it had been abolished by EGTA. Magnesium, sodium, and potassium did not affect EGTA inhibition of adherence. Five of the cations tested (zinc, mercury, iron, lead, and copper) caused autoagglutination of isolates 87, 11OH, and 11ONH. Four other cations tested (lithium, cesium, tin, and barium) caused a substantial decrease (70%) in the number of adherent fibroblasts.
Citrate reversal of adherence. Citrate, a compound that was able to inhibit the adherence of rough-and intermedi- ate-phase isolates, also released adherent bacteria from HLF (Fig. 1) . Although citrate had no effect on the adherence of the smooth-phase isolate, it released the intermediate-and rough-phase isolates from HLF. Half of the rough-phase bacteria were adherent after 10 min, and half of the intermediate-phase bacteria were adherent after 16 min. Citrate also inhibited and reversed the adherence of 11 additional roughand intermediate-phase isolates tested. However, intermediate-and rough-phase isolates incubated with citrate and washed free of unbound citrate still adhered to HLF.
Effect of N-acetylated compounds and amino sugars on adherence. Isolates 110H, 87, and 110NH were incubated with various N-acetylated compounds before being exposed to HLF (Table 4 ). The most inhibitory compounds were GlcNAc and N-acetylmuramic acid, which inhibited 100 and 96% of the adherence of isolate 110H, respectively. Other N-acetylated compounds, such as N-acetylgalactosamine, N-acetylmannosamine, and N-acetylcysteine, inhibited the adherence of isolate 110H by 50, 36, and 43, respectively. Of the three amino sugars tested, only glucosamine inhibited the adherence of isolate 110H (50% inhibition). The N-ace- tylated compounds and amino sugars had no effect on the adherence of isolates 87 and 11ONH. All three isolates adhered to HLF which had been incubated with GlcNAc and washed free of unbound GlcNAc before being used in the adherence assay. The effect of GlcNAc was concentration dependent, with concentrations of 0.25 M or above being completely inhibitory (Fig. 2) . GlcNAc at a concentration of 0.125 M inhibited the adherence of isolate 110H by ca. 50%, whereas a 0.065 M concentration did not affect adherence.
GlcNAc reversal of adherence. GlcNAc, which inhibited the adherence of isolate 110H, also reversed its adherence to HLF (Fig. 3) . After ca. 20 min, 50% of the smooth-phase bacteria were released from HLF, and by 45 min, 96% were released. GlcNAc also inhibited and reversed the adherence of three additional smooth-phase isolates tested of B. bronchiseptica to adhere to HLF by 97% or more (Table 5 ). Protease K treatment of the smooth-, intermediate-, and rough-phase isolates completely eliminated their ability to adhere. Trypsin or Formalin treatment had no effect on adherence. As determined by EM, pili or flagella could not be detected after heat inactivation, homogenization, or protease K treatment, provided that the last two treatments were done in the presence of chloramphenicol. In the absence of the antibiotic, the bacteria possessed normalappearing pili and flagella by 30 min after treatment and could adhere to HLF. The presence of flagella was highly variable with regard to bacterial adherence; the smoothphase isolate was rarely flagellated, and the rough-and intermediate-phase isolates were frequently flagellated. Fibroblast treatment. Isolates 110H, 87, and 11ONH adhered as well to HLF which had been treated with neurami- The effect of bacterial homogenates containing isolated pili on adherence to HLF is shown in Table 6 . The presence of pili in the homogenates was confirmed by EM. In addition to pili and membrane fragments, flagella were also observed for isolates 87 and 11ONH. Homogenates obtained from either the smooth-or the intermediate-phase isolate caused at least a twofold increase in the number of adherent bacteria of either phase. However, homogenates obtained from the rough-phase isolate enhanced the adherence of only the rough-phase isolate. When enhancement was observed, the pattern of adherent bacteria, instead of being single, uniformly distributed bacterial cells, was more uneven, and clumps of adherent bacteria were observed.
Binding of radiolabeled GlcNAc to B. bronchiseptica. The binding of radiolabeled GlcNAc to smooth-and intermediate-phase isolates was measured. GlcNAc did not bind to the rough-phase isolate. GIcNAc bound to the smooth-phase isolate more rapidly (5.6 ng/min per 107 CFU) than to the intermediate-phase isolate (1.3 ng/min per 107 CFU). Equilibrium binding to GlcNAc was apparent after 20 min for the smooth-phase isolate and after 10 min for the intermediatephase isolate. The rates of GlcNAc binding at 4 and 37°C were similar for each isolate. Additionally, the smooth-phase isolate had a greater capacity to bind GlcNAc than did the intermediate-phase isolate. The calculated maximum amount of GLcNAc bound to the smooth-phase isolate was 60 ng/107 CFU. Saturation binding was similar at 4 GlcNAc did not bind to bacteria which had been homogenized or treated with protease K. Additionally, all radioactivity associated with 110H and 87 cells was removed by homogenization.
DISCUSSION
These investigations indicate that there are at least two mechanisms for B. bronchiseptica adherence. One involves (10, 16) . However, beyond the identification of the adherence-blocking substance, little is known concerning the interaction between a bacterial cell and the compound postulated to be a receptor component. Furthermore, it is uncertain whether these compounds act by mimicking receptors or by competing with adhesins for receptor binding sites (9, 11) . In the present study, GIcNAc appears to be the most important amino sugar residue in the adherence of the smooth-phase isolate to HLF, but partial inhibition of binding by other N-acetylated amino sugars suggests that these bacteria recognize the N-acetyl group as a binding-site component. Sugars which lacked this group, with the exception of glucosamine, did not alter binding. In addition, the third carbon of the glucose moiety of GlcNAc does not appear to be involved in binding, as N-acetylmuramic acid, which has a substitution at this position, inhibited 96% of adherence. Because bacteria with bound GlcNAc were nonadherent, whereas HLF treated with it still bound bacteria to their surfaces and because the binding of radiolabeled [3H]GlcNAc to the smooth-phase isolate was saturable and reversible, it appears that GlcNAc inhibits bacterial attachment by binding to the bacterial cell. This binding appears to be the result of a ligand, receptor interaction and not transport into the bacterial cell, as GlcNAc was not utilized as a carbon source, the level and rate of [3H]GlcNAc binding were not significantly different at 4 and 37°C, homogenization or protease K treatment prevented radiolabel binding, and all cell-associated radioactivity was eliminated by homogenization. Based on these observations, it was not surprising that GIcNAc also inhibited adherence to human buccal cells by smooth-phase bacteria, as it is one of the predominant sugars which make up the mammalian cell surface (15) .
In contrast, the adherence of the rough-and intermediatephase isolates was inhibited by various cationic chelators. The relative ability of these compounds to block adherence appeared to be correlated with their ability to bind divalent cations (13) . EGTA, a chelating agent with a high selectivity for calcium and the most effective inhibitor of binding, was overcome by calcium, strontium, manganese, or cadmium, thus indicating that these divalent cations were involved in binding. One mechanism by which they could affect adherence is neutralization of the surface charge. The influence of the surface charge on the interaction of bacteria with mammalian cells or glass has been demonstrated by several investigators (5, 17, 21) . The importance of this adherence mechanism was shown by Heckels et al. (7), who reported that pili reduced the negative charge on gonococcal surfaces. He further showed that neutralization of the negatively charged surfaces of nonpiliated gonococci by chemical modification of the amino and carboxyl groups on the bacterial cell surfaces increased the adherence of the nonpiliated organisms to the same level as that observed for piliated gonococci.
As with the smooth-phase isolate, the adhesin(s) that mediates the adherence of the rough-and intermediatephase isolates can be removed by homogenization or protease K treatment of the bacteria. Both of these treatments also denude the cells of pili. In addition, if these treatments VOL. 46, 1984 on October 19, 2017 by guest http://iai.asm.org/ Downloaded from are done in the absence of chloramphenical, the bacteria regain both their pili and the ability to adhere within 30 min after treatment. Based on the above results, one would predict that isolated pili should block attachment in a manner similar to that observed in E. coli (18) . This was not the case. Instead of adherence being inhibited, enhancement of adherence was observed. This enhancement may be related to the ability of the organism to autoagglutinate, as clumps of bacteria as well as single cells were observed bound to HLF. Bacterial aggregation is related to the hydrophobic properties of pili (2). Alternatively, it is possible that the isolated pilus preparations caused hidden receptors or adhesin(s) or both to be expressed. A third possibility is that the binding of pili or another bacterial adhesin in these preparations resulted in a localized reduction of the negative charge on HLF surfaces, thus allowing for a better interaction between the bacteria and the mammalian cells. It is clear that this phenomenon requires further examination.
For B. bronchiseptica, mutants that are either noninfectious or nonadherent have not been reported; therefore no definitive correlation can be made between its binding properties and pathogenicity. The information provided herein, through the use of an in vitro binding system, provides a basis on which such a correlation could be made. It is of interest that in the HLF system, which represents cells derived from an animal susceptible to infection, the level of adherence was similar, although the mechanisms for binding varied. This can be attributed to the assay parameters set, as adherence was measured at binding equilibrium (data not shown). At equilibrium (30 min), the level of adherence for all phases was similar. However, the other binding kinetics in this system, i.e., saturability and rate of binding, were dissimilar for the three phases.
This study indicates that B. bronchiseptica can interact with HLF in one of at least two ways, either by specifically binding to GlcNAc or a closely related cell surface component or by a divalent-cation-mediated event. Further, the effect of GlcNAc or cationic chelators on B. bronchiseptica adherence appears to be a general phenomenon, not limited to HLF, as the ability of these compounds to inhibit adherence to human buccal epithelial cells was comparable to that observed with HLF monolayers.
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